مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

19
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

19
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Effect of Statin Treatment on COVID-19 Patients’,Outcomes: A Randomized Double-blind Controlled Clinical Trial

Pages

  89-98

Abstract

 Background: Statins may be protective against viral infection and have been suggested for the treatment of coronavirus disease 2019 (COVID-19). Objective: In this study, we aimed to evaluate the effect of Atorvastatin on COVID-19 patients. Methods: Our study is a randomized double-blind controlled Clinical Trial that constitutes a population of COVID-19 patients admitted to Bu-Ali Sina Hospital in Qazvin, Iran, from May to August 2021. For the intervention and control groups, in addition to the national standard treatment, Atorvastatin 40 mg tablet and placebo were daily administered for 7 days, respectively. A questionnaire including demographic characteristics, history of underlying diseases, vital signs, laboratory and imaging results, and outcome (alive, died) was completed on the first, third, and fifth days of hospitalization. Finally, the obtained data were analyzed by SPSS software, version 25. Findings: One hundred five patients with COVID-19 (62 females and 43 males, mean age 69 years) were studied. On days 3 and 5 after the intervention, no significant difference was observed between the groups in terms of vital signs, laboratory findings, hospitalization time, and need for intensive care unit hospitalization. However, 5. 7% of patients in the Atorvastatin group and 0% of patients in the control group died (P=0. 243). Among the studied variables, C-reactive protein (P=0. 227 vs P=0. 002), blood urea nitrogen (P=0. 055 vs P<0. 001), and creatinine (P=0. 598 vs P=0. 013) decreased significantly in the statin group (no control group during days 0-5). Conclusion: There was no evidence about the harm and benefits of statin treatment during COVID-19 hospitalization.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Bahadori, Rozita, DODANGEH, SAMIRA, Nabavi, Seyedeh Azam, & ALLAMI, ABBAS. (2022). Effect of Statin Treatment on COVID-19 Patients’,Outcomes: A Randomized Double-blind Controlled Clinical Trial. JOURNAL OF INFLAMMATORY DISEASES (THE JOURNAL OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES), 26(2), 89-98. SID. https://sid.ir/paper/1068723/en

    Vancouver: Copy

    Bahadori Rozita, DODANGEH SAMIRA, Nabavi Seyedeh Azam, ALLAMI ABBAS. Effect of Statin Treatment on COVID-19 Patients’,Outcomes: A Randomized Double-blind Controlled Clinical Trial. JOURNAL OF INFLAMMATORY DISEASES (THE JOURNAL OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES)[Internet]. 2022;26(2):89-98. Available from: https://sid.ir/paper/1068723/en

    IEEE: Copy

    Rozita Bahadori, SAMIRA DODANGEH, Seyedeh Azam Nabavi, and ABBAS ALLAMI, “Effect of Statin Treatment on COVID-19 Patients’,Outcomes: A Randomized Double-blind Controlled Clinical Trial,” JOURNAL OF INFLAMMATORY DISEASES (THE JOURNAL OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES), vol. 26, no. 2, pp. 89–98, 2022, [Online]. Available: https://sid.ir/paper/1068723/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button